Neurogene (NASDAQ:NGNE) Price Target Raised to $72.00 at Leerink Partners
Neurogene (NASDAQ:NGNE – Free Report) had its price target hoisted by Leerink Partners from $45.00 to $72.00 in a research report released on Tuesday,Benzinga reports. Leerink Partners currently has an outperform rating on the stock. Several other analysts also recently weighed in on the company. Robert W. Baird boosted their target price on Neurogene from […]
More Stories
Prestige Consumer Healthcare Inc. (NYSE:PBH) Receives Average Rating of “Moderate Buy” from Analysts
Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH – Get Free Report) have been assigned an average rating of “Moderate Buy”...
Revance Therapeutics (NASDAQ:RVNC) Coverage Initiated by Analysts at StockNews.com
StockNews.com began coverage on shares of Revance Therapeutics (NASDAQ:RVNC – Free Report) in a research report report published on Sunday....
Energy Focus (NASDAQ:EFOI) Now Covered by Analysts at StockNews.com
StockNews.com initiated coverage on shares of Energy Focus (NASDAQ:EFOI – Free Report) in a research report released on Sunday morning....
Marchex (NASDAQ:MCHX) Coverage Initiated at StockNews.com
StockNews.com began coverage on shares of Marchex (NASDAQ:MCHX – Free Report) in a research report sent to investors on Sunday....
NetSol Technologies (NASDAQ:NTWK) Now Covered by StockNews.com
StockNews.com initiated coverage on shares of NetSol Technologies (NASDAQ:NTWK – Free Report) in a research report sent to investors on...
Analysts Set Nexstar Media Group, Inc. (NASDAQ:NXST) Target Price at $199.71
Nexstar Media Group, Inc. (NASDAQ:NXST – Get Free Report) has earned an average rating of “Moderate Buy” from the eight...